JP2006052172A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006052172A5 JP2006052172A5 JP2004235253A JP2004235253A JP2006052172A5 JP 2006052172 A5 JP2006052172 A5 JP 2006052172A5 JP 2004235253 A JP2004235253 A JP 2004235253A JP 2004235253 A JP2004235253 A JP 2004235253A JP 2006052172 A5 JP2006052172 A5 JP 2006052172A5
- Authority
- JP
- Japan
- Prior art keywords
- derivatives
- pyrazolone
- phenyl
- methyl
- preparation according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 claims description 7
- JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical compound O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 claims description 6
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical class O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 150000003017 phosphorus Chemical class 0.000 claims description 3
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical class OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims 3
- 239000007788 liquid Substances 0.000 claims 2
- 239000008267 milk Substances 0.000 claims 2
- 210000004080 milk Anatomy 0.000 claims 2
- 235000013336 milk Nutrition 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- 238000010521 absorption reaction Methods 0.000 claims 1
- 239000003623 enhancer Substances 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 229920000858 Cyclodextrin Polymers 0.000 description 6
- QELUYTUMUWHWMC-UHFFFAOYSA-N edaravone Chemical compound O=C1CC(C)=NN1C1=CC=CC=C1 QELUYTUMUWHWMC-UHFFFAOYSA-N 0.000 description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- -1 cinnamoyl Chemical group 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- FTCOWMWIZNVSPP-UHFFFAOYSA-N 2-phenyl-4h-pyrazol-3-one Chemical compound O=C1CC=NN1C1=CC=CC=C1 FTCOWMWIZNVSPP-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000004080 3-carboxypropanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C(O[H])=O 0.000 description 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 238000004455 differential thermal analysis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical group C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004235253A JP4746856B2 (ja) | 2004-08-12 | 2004-08-12 | ピラゾロン系製剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004235253A JP4746856B2 (ja) | 2004-08-12 | 2004-08-12 | ピラゾロン系製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006052172A JP2006052172A (ja) | 2006-02-23 |
| JP2006052172A5 true JP2006052172A5 (enExample) | 2007-09-27 |
| JP4746856B2 JP4746856B2 (ja) | 2011-08-10 |
Family
ID=36029873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004235253A Expired - Fee Related JP4746856B2 (ja) | 2004-08-12 | 2004-08-12 | ピラゾロン系製剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4746856B2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE031463T2 (en) * | 2007-01-19 | 2017-07-28 | Hananja Ehf | Method and compositions for administering an active ingredient |
| WO2009041714A1 (ja) * | 2007-09-26 | 2009-04-02 | Mikasa Seiyaku Co., Ltd. | フリーラジカル性疾患用外用剤 |
| EP2230912A4 (en) * | 2007-11-21 | 2013-05-01 | Teikoku Pharma Usa Inc | EMULSION FORMULATIONS OF PYRAZOLON DERIVATIVES |
| CN101524352A (zh) | 2008-03-04 | 2009-09-09 | 江苏先声药物研究有限公司 | 一种含有3-甲基-1-苯基-2-吡唑啉-5-酮的组合物 |
| CN101953832B (zh) * | 2010-08-10 | 2012-02-15 | 南京师范大学 | β-环糊精包合依达拉奉的口服药物组合物及其制备方法 |
| JP2014518228A (ja) * | 2011-07-01 | 2014-07-28 | フオンダツイオーネ・イステイトウート・インスブリコ・デイ・リチエルカ・ペル・ラ・ビータ | 高速溶解速度を有する非晶質トモキシプロールとシクロデキストリンとの複合体およびこの調製方法 |
| ES2928785T3 (es) * | 2017-10-13 | 2022-11-22 | Treeway Tw001 B V | Sal de edaravona |
| GB202103807D0 (en) * | 2021-03-18 | 2021-05-05 | Johnson Matthey Plc | A crystalline salt of edaravone, processes for the preparation and use thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2906512B2 (ja) * | 1990-01-16 | 1999-06-21 | 三菱化学株式会社 | 抗潰瘍剤 |
| JP3176716B2 (ja) * | 1991-06-21 | 2001-06-18 | 武田薬品工業株式会社 | 溶解性が向上した難水溶性薬物組成物 |
| DE4333598A1 (de) * | 1993-10-01 | 1995-04-06 | Consortium Elektrochem Ind | Verfahren zur Herstellung von alkylierten Cyclodextrin-Derivaten, nach dem Verfahren herstellbare methylierte Cyclodextrin-Derivate und die Verwendung der Produkte |
| JPH10279480A (ja) * | 1997-04-07 | 1998-10-20 | Mitsubishi Chem Corp | 皮膚組織障害の予防・治療剤 |
| CA2446837C (en) * | 2001-05-11 | 2012-01-03 | Mitsubishi Pharma Corporation | Stable high-concentration injection containing pyrazolone derivative |
| JP2003081830A (ja) * | 2001-09-12 | 2003-03-19 | Mitsubishi-Tokyo Pharmaceuticals Inc | 酸化ストレス抑制剤 |
| CN1232539C (zh) * | 2002-05-10 | 2005-12-21 | 刘云清 | 有机药物与倍他环糊精衍生物的配合物及其制备方法 |
| JP2004300153A (ja) * | 2003-03-20 | 2004-10-28 | Kiyoshi Kurokawa | 蛋白修飾物生成抑制剤 |
-
2004
- 2004-08-12 JP JP2004235253A patent/JP4746856B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5646131A (en) | Method for solubilizing drugs using cyclodextrins and carboxylic acids | |
| ES2525257T3 (es) | Composiciones de ciclopolisacárido y de bendamustina | |
| Salústio et al. | Advanced technologies for oral controlled release: cyclodextrins for oral controlled release | |
| Sharma et al. | Development of taste masked film of valdecoxib for oral use. | |
| MD20070267A (en) | Gastroresistant pharmaceutical formulation containing rifaximin | |
| JP2002332234A (ja) | ボリコナゾールを含有する薬剤製剤 | |
| JP5412709B2 (ja) | 改良された経口及び経粘膜デリバリーのためのクラドリビン製剤 | |
| JP2008526757A5 (enExample) | ||
| JPWO1999061061A1 (ja) | 薬物複合体 | |
| JP2008505902A5 (enExample) | ||
| CN1223347C (zh) | 注射用西洛他唑水性制剂 | |
| JP2010132681A (ja) | 向上した薬物動態特性を有する組成物 | |
| WO2004089418A1 (en) | A fluoroquinolone aqueous formulation of a ph between 4 and 7 comprising i.a. cyclodextrin, hydroxyacid | |
| JP2006052172A5 (enExample) | ||
| NZ237583A (en) | Preparation of piroxicam - cyclodextrin complexes and pharmaceutical compositions thereof | |
| JP2006219501A (ja) | 懸濁形態でのアリール複素環活性薬物の蓄積製剤 | |
| US20090074874A1 (en) | Process for Producing Polymer Micelles Encapsulating Low Molecular Weight Drugs | |
| BRPI0311511B1 (pt) | "preparações farmacêuticas líquidas, e sua aplicação". | |
| US9284341B2 (en) | Rapidly dissolving pharmaceutical composition | |
| JP2003504312A5 (enExample) | ||
| Fenyvesi et al. | Controlled release of drugs from CD polymers substituted with ionic groups | |
| JP2003520252A5 (enExample) | ||
| KR100834148B1 (ko) | 이트라코나졸을 유효성분으로 하는 약학적 조성물 | |
| JP2006052172A (ja) | ピラゾロン系製剤 | |
| TW200914028A (en) | Pirenoxine contented two liquid applying eye drop medicine |